TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
INDP

Indaptus Therapeutics Inc

Healthcare · Biotechnology

2.30$ -19.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INDP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
64.8% 89.0% 83.6% 87.3% 70.8% 64.6% 97.4% 99.5% 97.1% 93.8% 90.2% 100.0%
46.4% 63.8% 66.5% 82.7% 63.8% 43.7% 92.1% 96.4% 34.3% 89.5% 78.9% 91.4%
62.5% 82.7% 74.0% 85.5% 66.0% 47.3% 92.1% 96.4% 94.2% 89.5% 78.9% 91.4%
2.1% 2.1% 2.9% 0.7% 3.3% 16.4% – 0.1% – – – –
– – – – – 0.0% 0.1% 0.4% 0.3% – – –
24.2% 4.4% 8.2% 8.9% 12.9% 45.8% 113.4% 11.5% 12.2% 19.1% 46.2% 66.1%
14.8% 3.5% 7.8% 8.9% 12.4% 39.2% 113.4% 11.3% 12.2% 18.6% 46.2% 66.1%
– – – – – 2.6% 5.4% 0.2% 0.3% 0.7% 1.1% –
– 1.7% 4.7% 2.9% 4.6% 16.5% 8.8% 6.5% 4.9% 5.4% 11.9% 5.8%
75.8% 95.6% 91.8% 91.1% 87.1% 54.2% -13.4% 88.5% 87.8% 80.9% 53.8% 33.9%
-342.7% -133.1% -253.3% -152.3% -230.6% -890.1% -447.7% -38.6% -106.9% -304.3% -823.6% -873.1%
0.9% 0.0% 0.0% 0.0% 0.0% 0.1% 1.0% 0.4% 1.1% 2.0% 4.6% 10.4%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?